Alkem Laboratories Share Price Target 2025 to 2030: Hello Friends, today we are going to give you complete information about Alkem Laboratories Share Price. If you want to know what is the future of Alkem Laboratories Share Price and what is its target? So we will give you complete information about Alkem Laboratories Share in detail.
Alkem Laboratories Share Price Target
If we talk about Alkem Laboratories Share Price Target, then its share is going to increase in the coming 10 years. Talking about its performance, this stock has performed well in the last few months and has given money to all the investors. Investors of Alkem Laboratories Share are increasing very fast and all the investors are also investing funds. If you are a long-term investor then this share will give you good returns.
Alkem Laboratories Company Details
Alkem Laboratories Limited is an Indian firm that operates globally in the pharmaceutical industry. Pharmaceutical and nutraceutical product development, production, and sales are the company’s activities. The company sells its products in the following therapeutic areas: central nervous system (CNS), oncology, urology, gynecology, dermatology, diabetes, cardiology, gastroenterology, osteoporosis, rheumatology, and vitamins, minerals, and nutrition.
Rx Products, Alkem Generics, and OTC Products are among its product offerings. Brands including Clavam, Pan, Pan-D, Taxim-O, A To Z NS, Xone, Taxim, Gemcal, Pipzo, and Ondem are among the products offered by the company. The Company’s Pharmaceuticals business is its main operating unit. It has about twenty-one manufacturing plants spread across several sites in the US and India. The company works in 40 countries and has about 800 brands.
Fundamental Details
- P/E Ratio (TTM): 37.25
- EPS (TTM): 131.58
- Dividend Yield: 1.02%
- Market Cap: ₹58,605Cr
Financial Details
| 2019 | 2020 | 2021 | 2022 | 2023 | |
| Revenue | Rs. 7,445 Cr | Rs. 8,449 Cr | Rs. 9,098 Cr | Rs. 10,797 Cr | Rs. 11,815 Cr |
| Profit | Rs. 774 Cr | Rs. 1,149 Cr | Rs. 1,618 Cr | Rs. 1,680 Cr | Rs. 1,007 Cr |
| Net Worth | Rs. 5,572 Cr | Rs. 6,309 Cr | Rs. 7,558 Cr | Rs. 8,847 Cr | Rs. 9,435 Cr |
Alkem Laboratories Share Price Target 2025 to 2030
Alkem Laboratories Share Price Target 2025 ₹42.56, 2026 ₹62.47, 2027 ₹87.28, 2028 ₹108.64, 2029 ₹135.39, 2030 ₹158.48.
| Alkem Laboratories Share Price Target | Price |
| Alkem Laboratories Share Price Target 2025 | ₹5370.56 |
| Alkem Laboratories Share Price Target 2026 | ₹5645.58 |
| Alkem Laboratories Share Price Target 2027 | ₹5928.74 |
| Alkem Laboratories Share Price Target 2028 | ₹6236.51 |
| Alkem Laboratories Share Price Target 2029 | ₹6529.34 |
| Alkem Laboratories Share Price Target 2030 | ₹6872.48 |
Alkem Laboratories Share Price Target 2025
If we predict Alkem Laboratories Share for 2025, then looking at the growth of this share, the expectation is that this share will increase the money of all the investors and will give profit to all the investors. Looking at the market growth of this share, it is expected that this share will grow from Upto ₹5370.56 by the end of 2025. Alkem Laboratories Share Price Target for 2025 is ₹5370.56.
| Alkem Laboratories Share Price Target 2025 | ₹5370.56 |
Alkem Laboratories Share Price Target 2030
Talking about Alkem Laboratories Share, this share is on a bullish trend every year and the year ending of this share is with profit only. If we talk about 2030, then it is expected that this share will close upto ₹6872.48 this year. Looking at the bullish trend of this stock, it is expected that this year too it will add profit by making the money of all its investors profitable. Alkem Laboratories Share Price Target for 2030 is ₹6872.48.
| Alkem Laboratories Share Price Target 2030 | ₹6872.48 |
Also Read: Alembic Pharmaceuticals Share Price Target
Also Read: Alembic Share Price Target
Also Read: Albert David Share Price Target
Also Read: Alankit Share Price Target
| Disclaimer: This article is for informational purposes only and should not be considered investment advice. The price targets or predictions provided are generated by a custom algorithm using deep learning, which may change due to market fluctuations, volume shifts, and market cycles. It is strongly recommended not to base investments solely on the target price mentioned. |